Inotiv, Inc. Announces Financial Results Reporting
Inotiv, Inc. (NASDAQ: NOTV), a recognized leader in contract research, is set to unveil its financial outcomes for the fiscal 2025 fourth quarter and full year results. This announcement, anticipated by stakeholders, will take place on a Wednesday in early December. Following the close of market trading, Inotiv will provide critical insights into its financial performance by discussing results from the fiscal year ending September 30, 2025.
Conference Call Details
The company will arrange a conference call on the same day at 4:30 p.m. Eastern Time to elaborate on its financial results. This call is an opportunity for interested parties to engage and gain deeper insights into the company's strategies and results.
To join the call, participants can dial the following numbers:
- 1-800-225-9448 (Domestic)
- 1-203-518-9708 (International)
- Conference ID: INOTIV
Accessing the Live Webcast
For those who prefer a digital format, a live webcast of the conference call will be available on Inotiv’s official website in the Investors section, making it accessible to a wider audience interested in the company's updates.
Should circumstances prevent attendance at the live event, an online replay will be made available in the same section, ensuring that all stakeholders have the ability to review the information discussed.
About Inotiv, Inc.
Inotiv, Inc. stands at the forefront of contract research organizations (CROs), dedicated to advancing drug discovery and development services. The company's expertise lies in providing comprehensive nonclinical and analytical services, along with innovative research models and essential tools for the biopharmaceutical industry.
Inotiv’s commitment extends beyond mere services; they strive to enhance the development process for new drugs and medical devices. By increasing efficiency, elevating the quality of data, and mitigating costs throughout the discovery and preclinical phases, Inotiv aims to support researchers and developers in bringing their innovations to market more effectively.
The Vision and Future of Inotiv
Inotiv is not merely a service provider but a partner in health innovation, committed to supporting the overarching mission of improving human health. The company’s dedication to helping researchers maximize the potential of their projects positions it as a pivotal player in the healthcare landscape.
Future goals include expanding their services and enhancing engagement with researchers on varied projects that can lead to transformative healthcare solutions.
Company Contact Information
For further inquiries regarding this announcement, stakeholders can reach out directly to:
Inotiv, Inc.
Beth A. Taylor, Chief Financial Officer
(765) 497-8381
beth.taylor@inotiv.com
Investor Relations
LifeSci Advisors
Steve Halper
(646) 876-6455
shalper@lifesciadvisors.com
Frequently Asked Questions
What is Inotiv, Inc. known for?
Inotiv, Inc. specializes in contract research organization services focusing on drug discovery and development.
When will Inotiv announce its financial results?
Inotiv will announce its fiscal 2025 financial results on December 3, 2025.
How can I participate in the conference call?
You can join the conference call by dialing the provided domestic or international numbers.
Is there a way to access the results if I miss the live call?
Yes, an online replay of the call will be available in the Investors section of Inotiv’s website.
Who can I contact for more information?
You can contact Beth A. Taylor, Chief Financial Officer, or Steve Halper for investor relations inquiries.
